Cervical cancer
CC · Oncology · 2 drugs · 2 indications
Cancer of the cervix. Often HPV-associated.
Competitive Landscape (2 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Keytruda | MRK | PD-1 inhibitor | Antibody | IV | APPROVED |
| Tivdak | GMAB | Tissue factor-targeting ADC | ADC | IV | APPROVED |
Indications (2)
Upcoming Catalysts
Sac-TMT + Keytruda - 1L NSCLC - Ph3 - Update (OptiTROP-Lung05)CLINICAL
MRK2026
Keytruda - LOE PreparationCOMPETITIVE
MRKOngoing
Data from Supabase · Updated 2026-03-24